Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
...ited about its potential to be an effective treatment option for type 1 diabetics," stated Dr. Paolo Pozzilli, Professor University Campus Bio-Medico, rome Italy. "We are pleased that an increasing number of excellent clinical researchers in Europe and North America have started DEFEND at their sit...Revealing the regulating mechanism behind signal transduction in the brain
...e regulation of this process works is still to be discovered. FMRP: controlling protein production Claudia Bagni (VIB, K.U.Leuven, University of rome Tor Vergata) has been studying the FMRP protein for years now. The absence of FMRP leads to the Fragile X syndrome, a mental handicap afflicting a tho...AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity
...re the systemic (as opposed to local) expression of therapeutic genes. Duchenne Muscular Dystrophy is such a disease, and together with La Sapienza in rome we will work very hard to develop a treatment for this wasting disorder for which there is currently no treatment." About Amsterdam Molecular Therap...Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials
... Wows rome audience with live study setup and launch... WAYLAND, Mass., March 20 /PR...gration with trial simulators such as tcVisualize. The Tourtellotte team in rome demonstrated this concept by soliciting a live study design from the audien...Researchers outline structure of largest nonvirus particle ever crystallized
... The team of researchers at UCLA is led by David Eisenberg and Leonard H. rome of the departments of biological chemistry at the Geffen School of Medicine...arrel with staves. It is unlike any other large structure found in nature," rome said. "The outside of the vault structure is like an eggshell a continuous...